✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Gufic Biosciences Ltd.

GUFICBIO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,728 Cr.
P/E
60.26

Gufic Biosciences Ltd.

  • Gufic Biosciences
  • Unichem Lab
  • Orchid Pharma
  • TJI Pharma - Small Cap

FAQs on Gufic Biosciences Ltd. Shareprice

Gufic Biosciences has given better returns compared to its competitors.
Gufic Biosciences has grown at ~20.56% over the last 8yrs while peers have grown at a median rate of 9.41%

Yes, Gufic Biosciences is expensive.
Latest PE of Gufic Biosciences is 60.26, while 3 year average PE is 35.09.
Also latest EV/EBITDA of Gufic Biosciences is 30.32 while 3yr average is 21.43.

View FAQ's On Business

Growth Table

  • Gufic Biosciences Ltd.
  • Unichem Lab
  • Orchid Pharma

Balance Sheet

  • Gufic Biosciences Ltd.
  • Unichem Lab
  • Orchid Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Gufic Biosciences Ltd.
  • Unichem Lab
  • Orchid Pharma

Cash Flow

  • Gufic Biosciences Ltd.
  • Unichem Lab
  • Orchid Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Gufic Biosciences Ltd.
  • Unichem Lab
  • Orchid Pharma

Quarterly Results

  • Gufic Biosciences Ltd.
  • Unichem Lab
  • Orchid Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Gufic Biosciences Ltd. Financials

Balance sheet of Gufic Biosciences is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Gufic Biosciences is decreasing.
Latest net debt of Gufic Biosciences is ₹281 Crs as of Mar-25.
This is less than Mar-24 when it was ₹291 Crs.

The profit is oscillating.
The profit of Gufic Biosciences is ₹61.87 Crs for TTM, ₹86.14 Crs for Mar 2024 and ₹79.7 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gufic Biosciences latest dividend payout ratio is 1.16% and 3yr average dividend payout ratio is 1.13%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech